Human Immunology News Volume 12.03 | Jan 30 2024

    0
    37








    2024-01-30 | HIN 12.03


    Human Immunology News by STEMCELL Technologies
    Vol. 12.03 – 30 January, 2024
    TOP STORY

    Differential Peripheral Immune Signatures Elicited by Vegan versus Ketogenic Diets in Humans

    Using a multiomics approach including multidimensional flow cytometry, transcriptomic, proteomic, metabolomic, and metagenomic datasets, the authors assessed the impact of each diet, and dietary switch, on host immunity and the microbiota.
    [Nature Medicine]

    Full Article
    Learn more about using human primary cells for your assays
    PUBLICATIONSRanked by the impact factor of the journal

    MHC-I Upregulation Safeguards Neoplastic T Cells in the Skin against NK Cell-Mediated Eradication in Mycosis Fungoides

    Researchers employed a clonality-supervised deep learning methodology to dissect key pathological features implicated in mycosis fungoides, the most common cutaneous T-cell lymphoma.
    [Nature Communications]

    Full Article

    Expression of E-Cadherin by CD8+ T Cells Promotes Their Invasion into Biliary Epithelial Cells

    Investigators characterized the mechanism of CD8+ T cell invasion into biliary epithelial cells (BECs). CD8+ T cells observed within BEC were large, eccentric, and expressed E-cadherin, CD103, and CD69.
    [Nature Communications]

    Full Article

    Human Tumor-Associated Macrophages and Neutrophils Regulate Anti-Tumor Antibody Efficacy through Lethal and Sublethal Trogocytosis

    The authors found that myeloid effectors interacting with tumor-targeting antibody-opsonized lung cancer cells employed antibody-dependent trogocytosis but not antibody-dependent phagocytosis.
    [Cancer Research]

    Abstract

    NKG2A+CD8+ T Cells Infiltration Determines Immunosuppressive Contexture and Inferior Response to Immunotherapy in Clear Cell Renal Cell Carcinoma

    Researchers included four independent cohorts, including 234 patients who underwent partial or radical nephrectomy at Zhongshan Hospital, and 117 metastatic patients who were treated with immune checkpoint inhibitor or tyrosine kinase inhibitor alone.
    [Journal For Immunotherapy Of Cancer]

    Full Article

    Beneficial Effect of Temporary Methotrexate Interruption on B and T Cell Responses upon SARS-CoV-2 Vaccination in Patients with Rheumatoid Arthritis or Psoriatic Arthritis

    B and T cell responses were evaluated in patients with rheumatoid arthritis or psoriatic arthritis after one or two weeks of methotrexate (MTX) withdrawal following each COVID-19 vaccine dose and compared with those who maintained MTX.
    [npj Vaccines]

    Full Article

    Immune Evasion in Lung Metastasis of Leiomyosarcoma: Upregulation of EPCAM Inhibits CD8+ T Cell Infiltration

    Investigators analyzed the immune environment of primary and lung metastases in 38 patients with soft tissue sarcoma using immunohistochemistry.
    [British Journal of Cancer]

    Full Article

    Identification of an Immune-Related eRNA Prognostic Signature for Clear Cell Renal Cell Carcinoma

    Researchers retrieved eRNA expression profiles from TCGA database and identified immune-related eRNAs by assessing their co-expression with immune genes.
    [Aging-Us]

    Full Article

    Reprogramming Macrophage by Targeting VEGF and CD40 Potentiates OX40 Immunotherapy

    To explore the mechanism underlying the action of anti-OX40 agonists to improve the anti-tumor efficacy, scientists analyzed the dynamic changes of tumor-infiltrating immune cells at different days post-treatments using single-cell RNA-sequencing.
    [Biochemical and Biophysical Research Communications]

    Abstract
    Gentle human T cell activation with ImmunoCultâ„¢
    REVIEWS

    New Immune Cell Engagers for Cancer Immunotherapy

    Agents designed to engage the antitumour activities of other immune cells, including natural killer cells and myeloid cells, are showing promise and have the potential to treat a broader range of cancers.
    [Nature Reviews Immunology]

    Abstract

    Established and Emerging Biomarkers of Immunotherapy in Renal Cell Carcinoma

    The authors discuss biomarkers for immunotherapy in renal cell carcinoma (RCC), highlighting current practices and emerging innovations, aiming to contribute to improved outcomes for patients with RCC.
    [Immunotherapy]

    AbstractGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Sanofi Pays Synthekine $40M to Join Preclinical Push against Vexing Inflammatory Target

    Sanofi is paying $40 million to add another cytokine—IL-10—to its hit list. This has secured Sanofi the chance to work with Synthekine to overcome long-standing barriers to the use of the cytokine in the treatment of inflammatory diseases.
    [Fierce Biotech]

    News Article
    FEATURED EVENT

    Microbiome Interactions in Health and Disease

    February 14 – 16, 2024
    Hinxton, England, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Tenure-Track Faculty – Integrative Biology and Physiology

    University of Minnesota – Minneapolis, Minnesota, United States

    Senior Process Engineer – CAR T cells

    Cellistic – Mont-Saint-Guibert, Belgium

    Postdoctoral Scientists – New Immune Checkpoints and Immunotherapies

    Albert Einstein College of Medicine – New York, New York, United States

    Research Assistant – T Cell Biology & Human Immunology

    Karolinska Institutet – Solna, Sweden

    Principal Investigators – Human Cell Lineage Atlas Facility

    Guangzhou Institutes of Biomedicine and Health – Guangzhou, China

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2